STOCK TITAN

RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

At TIDES 2022, SCIEX announced the launch of the RNA 9000 Purity & Integrity kit designed for high-resolution analysis of mRNA therapeutics. This kit enhances the integrity and quality control of RNA, essential for RNA-based therapeutics and vaccines amidst a growing demand. The kit is compatible with the BioPhase 8800 and PA 800 Plus systems, streamlining analysis and reducing time to market. It allows scientists to accurately gauge therapeutic sizes and detect low-level impurities, ultimately supporting the development of impactful RNA medicines.

Positive
  • Launch of the RNA 9000 Purity & Integrity kit enhances mRNA analysis capabilities.
  • Significantly higher resolution for various mRNA classes, improving product quality control.
  • Compatible with multiple SCIEX systems, allowing global accessibility.
  • Facilitates faster development of RNA-based therapeutics, aiding biopharmaceutical developers.
Negative
  • None.

Broad range RNA integrity and quality analysis kit for SCIEX capillary electrophoresis instruments launches at TIDES 2022

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- At TIDES 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches the RNA 9000 Purity & Integrity kit, for the BioPhase 8800 system and PA 800 Plus system.

As genomic medicine takes center stage and the demand for RNA-based therapeutics and vaccines grows, the integrity and quality of RNA species is increasingly important. Scientists have been faced with complex methods that have low resolution and poor transferability, as they work to accelerate therapeutic drug development and meet critical timelines. For intact mRNA analysis, scientists need validated, production-ready methods and instrument platforms that allow them to confidently distinguish desired therapeutic products from unwanted impurities.

This RNA 9000 Purity and Integrity kit is a purpose-built, high resolution analysis method for mRNA therapeutics. It was specifically designed to provide significantly higher resolution for a wide variety of therapeutically-relevant mRNA classes, from 50-9,000 bases.

“For scientists, this kit has the power and capability to transform the analysis of mRNA therapeutics and vaccines. Not only can it be used for final product quality control to assess quality and length post nanoparticle or viral vector encapsulation, but it can also be used during early-stage development immediately following IVT (in-vitro transcribe) to ensure the integrity and size of the mRNA payload is what the researchers are targeting. This kit is truly a unique solution with its analytical resolution,” said Jérémie Parot PhD, Research Scientist at SINTEF.

“The ability to help biopharmaceutical developers accelerate the development of RNA-based medicines and bridge the developability gap can bring more life-changing medicines to market,” said Susan Darling, Senior Director of CE and Biopharma at SCIEX. “Compatibility with both the BioPhase 8800 system and the PA 800 Plus system means scientists have the ability to run the assay in a 21cfr part 11b compliant way, across instruments, across sites, across the globe.”

With this kit, scientists could expect to:

  • Minimize time to market with exceptional reproducibility, experiment to experiment
  • Estimate a target therapeutic size
  • Experiment with minimal sample material and have the ability to detect low level impurities present in samples

To learn more about RNA 9000 Purity and Integrity kit, see here.

About SCIEX

SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. We have been at the forefront of the field of mass spectrometry for 50 years. From the launch of the first ever commercially successful triple quadrupole in 1981, we have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.

Today, as part of the Danaher Corporation (NYSE:DHR) family of global science and technology companies, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. Our customers can quickly respond to environmental hazards, better understand biomarkers relevant to disease, improve patient care in the clinic, bring relevant drugs to market faster and keep food healthier and safer.

That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.

For more information, visit sciex.com.

Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.

Advances in human wellness depend on the power of precise science.

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.

Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).

© 2022 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-14725-A.

Lulu VanZandt

Senior Manager, Brand, Public Relations and Social Media

lulu.vanzandt@sciex.com

M: +1 (508) 782-9484

Source: SCIEX

FAQ

What is the RNA 9000 Purity & Integrity kit?

It is a high-resolution analysis kit designed for mRNA therapeutics, launched by SCIEX at TIDES 2022.

How does the RNA 9000 kit benefit scientists?

It minimizes time to market, ensures high-quality control, and allows detection of low-level impurities in RNA samples.

Which systems is the RNA 9000 kit compatible with?

It is compatible with the BioPhase 8800 and PA 800 Plus systems.

What is the significance of the kit's launch for Danaher Corporation (DHR)?

The kit enhances SCIEX's product offerings in the RNA therapeutics field, potentially leading to increased demand and revenue.

When was the RNA 9000 Purity & Integrity kit launched?

It was launched at TIDES 2022.

Danaher Corporation

NYSE:DHR

DHR Rankings

DHR Latest News

DHR Stock Data

166.49B
722.28M
11%
81.78%
0.74%
Diagnostics & Research
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
WASHINGTON